1. Barré S, editor. Etat des lieux et recommandations pour le dépistage du cancer du col de l’utérus en france [Internet]. Haute Autorité de Santé; [cited 2016 Aug 25]. Available from:
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/synthese_recommandations_depistage_cancer_du_col_de_luterus.pdf
.
2. New Canadian Task Force guideline: Start Pap tests at age 25, not 18 | Canadian Women’s Health Network [Internet]. [cited 2017 Jan 7]. Available from:
http://www.cwhn.ca/en/node/45708
.
3. Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer Oxf Engl 1990. 2009;45:2649–58.
4. White A. Cancer Screening Test Use — United States, 2015. MMWR Morb Mortal Wkly Rep [Internet]. 2017 [cited 2018 Feb 8];66. Available from:
https://www.cdc.gov/mmwr/volumes/66/wr/mm6608a1.htm
.
5. Beltzer N, Hamers. (PDF) Final results of the evaluation of organized screening for cervical cancer in 13 departments in France, 2010-2014 [Internet]. ResearchGate. [cited 2018 Dec 17]. Available from:
https://www.researchgate.net/publication/312940050_Final_results_of_the_evaluation_of_organized_screening_for_cervical_cancer_in_13_departments_in_France_2010-2014
.